Abstract:Background: Microbes have been implicated in atherosclerosis development and progression, but the impact of bacterial-based biofilms on fibrous plaque rupture remains poorly understood. Results: Here, we developed a comprehensive atherosclerotic model to reflect the progression of fibrous plaque under biofilm-induced inflammation (FP-I). High expressions of biofilm-specific biomarkers algD, pelA and pslB validated the presence of biofilms. Biofilm promotes the polarization of macrophages to-wards a pro-inflammatory (M1) phenotype, as demonstrated by an increase in M1 macrophage-specific marker CD80 expression in CD68+ macrophages. The increase in the number of intracellular lipid droplets (LDs) and foam cell percentage highlighted the potential role of biofilms on lipid synthesis or metabolic pathways in macrophage-derived foam cells. In addition, collagen I production by myofibroblasts associ-ated with the fibrous cap was significantly reduced along with the promotion of apoptosis of myofibrob-lasts, indicating that biofilms affect the structural integrity of the fibrous cap and potentially undermine its strength. Conclusion: We validated the unique role of biofilm-based inflammation in exacerbating fibrous plaque damage in the FP-I model, increasing fibrous plaque instability and risk of thrombosis. Our results lay the foundation for mechanistic studies of the role of biofilms in fibrous plaques, allowing the evaluation of preclinical combination strategies for drug therapy. Statement of significance A microsystem-based model was developed to reveal interactions in fibrous plaque during biofilm-induced inflammation (FP-I). Real-time assessment of biofilm formation and its role in fibrous plaque progression was achieved. The presence of biofilms enhanced the expression of pro-inflammatory (M1) specific marker CD80, lipid droplets, and foam cells and reduced anti-inflammatory (M2) specific marker CD206 expression. Fibrous plaque exposure to biofilm-based inflammation reduced collagen I expression and increased apoptosis marker Caspase-3 expression significantly. Overall, we demonstrate the unique role of biofilm-based inflammation in exacerbating fibrous plaque damage in the FP-I model, promoting fibrous plaque instability and enhanced thrombosis risk. Our findings lay the groundwork for mechanistic studies, facilitating the evaluation of preclinical drug combination strategies.& COPY; 2023 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

The fibrous cap: a promising target in the pharmacotherapy of atherosclerosis

A two-phase model of early fibrous cap formation in atherosclerosis

Delineation of a thrombin receptor-stimulated vascular smooth muscle cell transition generating cells in the plaque-stabilising fibrous cap

Mechanisms of fibrous cap formation in atherosclerosis

Role of Lipid-Lowering and Anti-Inflammatory Therapies on Plaque Stabilization

A multiphase model of growth factor-regulated atherosclerotic cap formation

Reversal of Atherosclerotic Plaque Growth and Vulnerability: Effects of Lipid-Modifying and Anti-Inflammatory Therapeutic Agents

Mechanistic insights into the regression of atherosclerotic plaques

Smooth muscle cell fate and plasticity in atherosclerosis

Atherosclerotic plaque stabilization and regression: a review of clinical evidence

Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis

Lipid-laden Foam Cells in the Pathology of Atherosclerosis: Shedding Light on New Therapeutic Targets

Cholesterol lowering depletes atherosclerotic lesions of smooth muscle cell-derived fibromyocytes and chondromyocytes

S-propargyl-cysteine promotes the stability of atherosclerotic plaque via maintaining vascular muscle contractile phenotype

Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque

SMC Derived Hyaluronan Modulates Vascular SMC-Phenotype in Murine Atherosclerosis

Role of Vascular Smooth Muscle Cell Phenotypic Switching in Plaque Progression: A Hybrid Modeling Study

Navigating the landscape: Prospects and hurdles in targeting vascular smooth muscle cells for atherosclerosis diagnosis and therapy

A New Therapeutic End for Atherosclerotic Cardiovascular Disease

Biofilms Exacerbate Atherogenesis Through Macrophage-Induced Inflammatory Responses in a Fibrous Plaque Microsystem Model.

Atherosclerotic Plaque Erosion: Mechanisms, Clinical Implications, and potential therapeutic Strategies – a review